Status:

UNKNOWN

A Randomized Controlled Trial Evaluating One Drop | Premium With Afrezza vs. One Drop | Premium Alone

Lead Sponsor:

Informed Data Systems, Inc.

Collaborating Sponsors:

Mannkind Corporation

Conditions:

Diabetes Mellitus, Type 2

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

The A-One study is a prospective, randomized controlled trial evaluating the use of the One Drop \| Premium 'On Track' in combination with Afrezza treatment on the glycemic control, treatment adherenc...

Detailed Description

Eligible participants (N=400) with an A1c \> 7.0% already prescribed a rapid-acting insulin will be randomized to one of two groups: (1) One Drop \| Premium 'On Track' (i.e., use the One Drop \| Mobil...

Eligibility Criteria

Inclusion

  • 18-75 years of age
  • Self-reported diagnosis of T2D
  • Diagnosed with diabetes for at least 12 months
  • Prescribed a prandial rapid-acting insulin
  • Willing to take Afrezza rapid-acting insulin for 3 months instead of current rapid-acting insulin
  • Willing to get a physician's prescription for Afrezza
  • Self-reported A1c \> 7.0% (later confirmed with a mail-in A1c laboratory test)
  • Owns and uses an iPhone or Android phone with an operating system compatible with the One Drop \| Mobile app
  • Has successfully downloaded and used a smart phone application previously

Exclusion

  • Currently pregnant or planning to become pregnant during the trial period
  • Cannot read or write in English
  • Currently in a diabetes education or coaching program
  • Had previously used One Drop \| Premium or One Drop \|
  • Experts coaching
  • Had previously used or is currently using Afrezza
  • Currently smokes (cigaretts, e-cigs, pipes, cigars, marijuana) or has smoked anytime in the past 6 months
  • Has chronic lung disease, e.g., COPD and asthma

Key Trial Info

Start Date :

October 5 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2019

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT03313960

Start Date

October 5 2017

End Date

December 30 2019

Last Update

February 26 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

One Drop

New York, New York, United States, 10002